{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:52:51Z","timestamp":1791946371165,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmcl.2026.130590","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:20:48Z","timestamp":1771978848000},"page":"130590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and antibacterial activity of novel LpxC inhibitors containing 1,2,3-triazole moieties"],"prefix":"10.1016","volume":"136","author":[{"given":"Fangyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10474","key":"10.1016\/j.bmcl.2026.130590_bb0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(24)02081-6","article-title":"Multidrug-resistant gram-negative bacterial infections","volume":"405","author":"Macesic","year":"2025","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130590_bb0010","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130590_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa276","article-title":"Drugs for gram-negative bugs from 2010-2019: a decade in review","volume":"7","author":"Pontefract","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bmcl.2026.130590_bb0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu Rev Biochem"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130590_bb0025","doi-asserted-by":"crossref","first-page":"16969","DOI":"10.1074\/jbc.M413560200","article-title":"UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid-base catalyst pair mechanism","volume":"280","author":"Hernick","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130590_bb0030","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/bi048001h","article-title":"Kinetic analysis of the zinc-dependent deacetylase in the lipid A biosynthetic pathway","volume":"44","author":"McClerren","year":"2005","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.bmcl.2026.130590_bb0035","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2174\/1568026616666160413135835","article-title":"Insights into the zinc-dependent deacetylase LpxC: biochemical properties and inhibitor design","volume":"16","author":"Kalinin","year":"2016","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130590_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/138920108783497668","article-title":"Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis","volume":"9","author":"Barb","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130590_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107143","article-title":"Common and varied molecular responses of Escherichia coli to five different inhibitors of the lipopolysaccharide biosynthetic enzyme LpxC","volume":"300","author":"Moller","year":"2024","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.bmcl.2026.130590_bb0050","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.2174\/092986712800167374","article-title":"UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents","volume":"19","author":"Zhang","year":"2012","journal-title":"Curr Med Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130590_bb0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nsb948","article-title":"Structure of the LpxC deacetylase with a bound substrate-analog inhibitor","volume":"10","author":"Coggins","year":"2003","journal-title":"Nat Struct Biol"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130590_bb0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/bi101622a","article-title":"Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090","volume":"50","author":"Cole","year":"2011","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130590_bb0065","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/13543776.2017.1360282","article-title":"LpxC inhibitors: a patent review (2010-2016)","volume":"27","author":"Kalinin","year":"2017","journal-title":"Expert Opin Ther Pat"},{"issue":"708","key":"10.1016\/j.bmcl.2026.130590_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf5668","article-title":"Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens","volume":"15","author":"Zhao","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmcl.2026.130590_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116892","article-title":"Design, synthesis and evaluation of novel LpxC inhibitors containing a hydrazone moiety as gram-negative antibacterial agents","volume":"279","author":"Chen","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130590_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115326","article-title":"Small molecule LpxC inhibitors against gram-negative bacteria: advances and future perspectives","volume":"253","author":"Niu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130590_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.12.179","article-title":"LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: a long path explored for potent drug design","volume":"234","author":"Kumar Pal","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmcl.2026.130590_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2024.109057","article-title":"LpxC inhibition: potential and opportunities with carbohydrate scaffolds","volume":"537","author":"Amudala","year":"2024","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmcl.2026.130590_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1541379","article-title":"Recent advances in small molecule LpxC inhibitors against gram-negative bacteria (2014-2024)","volume":"16","author":"Ji","year":"2025","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130590_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051451","article-title":"The complex structure of protein AaLpxC from aquifex aeolicus with ACHN-975 molecule suggests an inhibitory mechanism at atomic-level against gram-negative bacteria","volume":"26","author":"Fan","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2026.130590_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144627","article-title":"Quinoline-integrated bis-triazole molecular hybrids: synthesis, in vitro, docking, and ADMET evaluation for antimalarial and antimicrobial potentials","volume":"1353","author":"Sulakhe","year":"2026","journal-title":"J Mol Struct"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130590_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127434","article-title":"Novel isoniazid embedded triazole derivatives: synthesis, antitubercular and antimicrobial activity evaluation","volume":"30","author":"Patil","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130590_bb0115","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/jhet.4072","article-title":"Synthesis of isoniazid-1,2,3-triazole conjugates: antitubercular, antimicrobial evaluation and molecular docking study","volume":"57","author":"Badar","year":"2020","journal-title":"J Heterocyclic Chem"},{"issue":"22","key":"10.1016\/j.bmcl.2026.130590_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127579","article-title":"Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents","volume":"30","author":"Phatak","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130590_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112686","article-title":"1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"206","author":"Xu","year":"2020","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:54:40Z","timestamp":1777600480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S0960894X26000570"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130590","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and antibacterial activity of novel LpxC inhibitors containing 1,2,3-triazole moieties","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130590"}}